Investigational drug Iluvien (fluocinolone acetonide intravitreal insert) for the treatment of diabetic macular edema cannot be approved in its present form, the FDA (Food and Drug Administration) wro
in its Complete Response Letter (CRL). Illuven is the result of a collaboration between pSdivida Corp. and Alimera Sciences Inc…
Source:medicalnewstoday.com
You may also lik:
Loading ...
Comments are closed.